INNOSPEC INC. IOSP

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived Nasdaq

Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Our Performance Chemicals business creates innovative technology-based solutions for the personal care, home care, agrochemical, construction, mining and other industrial markets. Our Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Our Oilfield Services business supplies chemicals for drilling, completion, production and drag reducing agents ("DRA") which make oil and gas exploration and production more cost-efficient and environmentally friendly.

Last close 98.64 2026-10-23
Market cap $2.43B 2026-06-30 share count
52-week range 65.51 - 100.48

Valuation FY2025 figures against the last close

P/S1.4x
P/E21.1x
P/FCF27.6x
EV/EBITDA14.0x
Dividend yield1.7%
Diluted EPS4.67

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.78B$1.85B$1.95B$1.96B$1.48B$1.19B$1.51B$1.48B$1.31B$883.4M
Cost of revenue $1.29B$1.30B$1.36B$1.38B$1.05B$850.4M$1.05B$1.04B$903.5M$551.1M
Gross profit $492.4M$542.9M$591.1M$586.7M$434.9M$342.7M$466.2M$435.0M$403.3M$332.3M
R&D $51.0M$56.5M$49.0M$38.7M$37.4M$30.9M$35.4M$33.4M$31.4M$25.4M
SG&A $285.1M$305.3M$380.5M$360.7M$267.2M$237.0M$280.9M$261.0M$244.2M$216.7M
Total operating expenses $362.9M$365.0M$429.5M$399.4M$302.8M$309.0M$316.3M$301.5M$278.3M$234.1M
Operating income $129.5M$177.9M$161.6M$187.3M$132.1M$33.7M$149.9M$133.5M$125.0M$98.2M
Pre-tax income $138.1M$41.2M$174.4M$184.6M$134.4M$39.7M$150.4M$131.6M$128.1M$103.1M
Income tax $21.5M$5.6M$35.3M$51.6M$41.3M$11.0M$38.2M$46.6M$66.3M$21.8M
Net income $116.6M$35.6M$139.1M$133.0M$93.1M$28.7M$112.2M$85.0M$61.8M$81.3M
EPS, basic 4.691.435.605.373.781.174.583.482.563.39
EPS, diluted 4.671.425.565.323.751.164.543.452.523.33
Shares, diluted (wtd. avg.) 25.0M25.1M25.0M25.0M24.9M24.8M24.7M24.6M24.5M24.4M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $292.5M$289.2M$203.7M$147.1M$141.8M$105.3M$75.7M$123.1M$90.2M$101.9M
Short-term investments —————————$0
Receivables $342.3M$341.7M$359.8M$334.6M$284.5M$221.4M$292.0M$279.7M$244.5M$154.4M
Inventory $329.3M$301.0M$300.1M$373.1M$277.6M$220.0M$244.6M$248.0M$209.8M$173.8M
Total current assets $1.00B$956.6M$885.7M$872.6M$728.1M$566.2M$630.3M$663.9M$561.5M$441.1M
Property, plant and equipment $286.1M$269.7M$268.3M$220.9M$214.4M$210.8M$198.7M$196.4M$196.0M$157.4M
Goodwill $2.0M$382.5M$399.3M$358.8M$364.3M$371.2M$363.0M$364.9M$361.8M$374.8M
Other intangibles $67.7M$65.4M$57.3M$45.0M$57.5M$75.3M$113.5M$136.3M$163.3M$144.4M
Total assets $1.83B$1.73B$1.71B$1.60B$1.57B$1.40B$1.47B$1.47B$1.41B$1.18B
Accounts payable $174.7M$163.8M$163.6M$165.3M$148.7M$98.7M$122.0M$126.8M$117.9M$59.6M
Short-term debt —————$0$0$21.4M$15.8M$10.3M
Total current liabilities $360.1M$371.4M$371.5M$405.8M$336.6M$252.4M$303.5M$296.6M$261.5M$183.1M
Long-term debt —————$0$58.6M$186.2M$202.6M$258.5M
Total liabilities $499.5M$518.6M$557.8M$563.3M$537.9M—————
Retained earnings $1.10B$1.02B$1.03B$924.2M$822.9M$758.6M$755.5M$668.3M$605.0M$561.8M
Total equity $1.33B$1.21B$1.15B$1.04B$1.03B$944.9M$918.9M$825.5M$794.3M$653.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $138.3M$184.5M$207.3M$81.7M$93.2M$145.9M$161.6M$104.9M$82.7M$105.5M
Depreciation and amortisation $43.6M$43.5M$39.3M$40.1M$42.7M$46.0M$47.6M$49.6M$50.4M$38.1M
Stock-based compensation $8.1M$8.5M$8.0M$6.7M$4.4M$5.8M$6.6M$4.9M$4.1M$3.3M
Capital expenditure $50.3M$41.4M$62.1M$39.6M$39.1M$29.7M$29.9M$28.9M$23.3M$16.5M
Investing cash flow -$75.1M-$62.0M-$111.8M-$42.1M-$36.2M-$29.7M-$31.0M-$35.5M-$29.6M-$209.1M
Financing cash flow -$63.9M-$35.3M-$39.0M-$33.7M-$20.0M-$86.8M-$177.9M-$36.2M-$66.4M$69.5M
Dividends paid $42.4M$38.8M$35.1M$31.7M$28.8M$25.6M$25.0M$21.7M$18.6M$15.9M
Buybacks $23.9M$700.0K$1.1M$5.9M$800.0K$2.1M$2.4M$1.4M$1.1M$8.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-056502.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 500M 1B 1.5B 2B Revenue, FY2016: 883.4M Gross profit, FY2016: 332.3M Net income, FY2016: 81.3M Revenue, FY2017: 1.3B Gross profit, FY2017: 403.3M Net income, FY2017: 61.8M Revenue, FY2018: 1.5B Gross profit, FY2018: 435M Net income, FY2018: 85M Revenue, FY2019: 1.5B Gross profit, FY2019: 466.2M Net income, FY2019: 112.2M Revenue, FY2020: 1.2B Gross profit, FY2020: 342.7M Net income, FY2020: 28.7M Revenue, FY2021: 1.5B Gross profit, FY2021: 434.9M Net income, FY2021: 93.1M Revenue, FY2022: 2B Gross profit, FY2022: 586.7M Net income, FY2022: 133M Revenue, FY2023: 1.9B Gross profit, FY2023: 591.1M Net income, FY2023: 139.1M Revenue, FY2024: 1.8B Gross profit, FY2024: 542.9M Net income, FY2024: 35.6M Revenue, FY2025: 1.8B Gross profit, FY2025: 492.4M Net income, FY2025: 116.6M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $883.4M $1.31B $1.48B $1.51B $1.19B $1.48B $1.96B $1.95B $1.85B $1.78B
Gross profit $332.3M $403.3M $435.0M $466.2M $342.7M $434.9M $586.7M $591.1M $542.9M $492.4M
Net income $81.3M $61.8M $85.0M $112.2M $28.7M $93.1M $133.0M $139.1M $35.6M $116.6M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Shareholder vote Item 5.07
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $9.44B 39.9x 3.1%
BCPC BALCHEM CORP $5.64B 37.3x 8.8%
PRM Perimeter Solutions, Inc. $4.55B — 16.4%
NGVT Ingevity Corp $2.39B — -2.7%
CC Chemours Co $1.93B — 0.4%
OLN OLIN Corp $1.78B — 3.7%
HUN Huntsman CORP $1.54B — -5.8%
ECVT Ecovyst Inc. $1.07B — 20.9%